Safety Study of DWP-450 (Botulinum Toxin, Type a) to Treat Glabellar Lines - EV-006
Clinical trial NCT02428608 · COMPLETED
Trial details
- NCT number
- NCT02428608
- Sponsor
- Evolus, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-05-01
- Primary completion
- 2016-10-01
- Enrollment
- 570
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.